Multigenetic Pharmacogenomics–Guided Treatment vs Treatment As Usual Among Hospitalized Men With Schizophrenia: A Randomized Clinical Trial

IMPORTANCE: Limited evidence supports multigenetic pharmacogenomics–guided treatment (MPGT) in schizophrenia. OBJECTIVE: To evaluate the clinical effectiveness of MPGT in schizophrenia in a randomized clinical trial (RCT). DESIGN, SETTING, AND PARTICIPANTS: This RCT was conducted from March 2020 to...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Zhewei, Qin, Ying, Sun, Yutao, Lu, Zhe, Sun, Yaoyao, Chen, Huan, Feng, Xiaoyang, Zhang, Yuyanan, Guo, Hua, Yan, Hao, Yue, Weihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559185/
https://www.ncbi.nlm.nih.gov/pubmed/37801319
http://dx.doi.org/10.1001/jamanetworkopen.2023.35518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559185/
https://www.ncbi.nlm.nih.gov/pubmed/37801319
http://dx.doi.org/10.1001/jamanetworkopen.2023.35518

Ejemplares similares